Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial

BACKGROUND: Chronic kidney disease is a common disease. Most chronic kidney diseases evolve from primary glomerulonephritis. Proteinuria is an independent risk factor for the progression of chronic kidney disease. The general consensus is that therapy administered to decrease proteinuria should incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kou, Jia, Wu, Jie, Yang, Hong-tao, He, Ya-ni, Fang, Jing-ai, Deng, Yue-yi, Xie, Yuan-sheng, Nie, Li-fang, Lin, Hong-li, Cai, Guang-yan, Chen, Xiang-mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289030/
https://www.ncbi.nlm.nih.gov/pubmed/25480673
http://dx.doi.org/10.1186/1745-6215-15-479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289030/
https://www.ncbi.nlm.nih.gov/pubmed/25480673
http://dx.doi.org/10.1186/1745-6215-15-479

Ejemplares similares